Physician profile
Abigail Bootes
NPI 1467912071
$914.05
in general payments reported to CMS, 2019-2025
11 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $310 · 2023: $80.44 · 2024: $336 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $197.17 | 2023-2024 | Slynd |
| Gynesonics, INC. | $190.04 | 2022 | |
| Mayne Pharma Commercial LLC | $129.65 | 2024-2025 | |
| Medtronic, INC. | $119.48 | 2022 | |
| Sage Therapeutics, LLC | $73.60 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $55.01 | 2024 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $44.27 | 2025 | Ova1 |
| Coopersurgical, INC. | $40.61 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $26.86 | 2025 | |
| Sumitomo Pharma America, INC. | $18.83 | 2024 | Myfembree |
| Merck Sharp & Dohme LLC | $18.53 | 2024 | Gardasil, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Bootes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.